Patents by Inventor Silke Thode

Silke Thode has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6537996
    Abstract: Compounds of formula 1 are effective modulators of p38 MAP kinase. wherein R1 is H, lower alkyl, or OR5, where R5 is aryl, heterocyclyl, acyl, N—R6-4-piperidinyl, N—R6-4-piperidinylmethyl, or N—R6-4-pipelidinylethyl, where aryl and heterocyclyl are substituted with 1-3 R6 substituents selected from the group consisting of H, lower alkyl, lower alkenyl, OH, NO2, NH2, halo, trihalomethyl, —CN, SH, SO, SO2, SO3H, —OR, —COR, —COOR, —CONHR, —OCOR, and —NCOR, where R is lower alkyl; R2 is H or lower alkyl; R3 is aryl substituted with 1-3 R6 substituents; R4 is H, lower alkyl, aryl, aralkyl, —OH, —NH2, —NHR, or —OR, where R is lower alkyl or aryl-lower alkyl; and A is —CH— or —N—; and pharmaceutically acceptable salts thereof.
    Type: Grant
    Filed: February 23, 2001
    Date of Patent: March 25, 2003
    Assignee: Iconix Pharmaceuticals, Inc.
    Inventors: David J. Morgans, Jr., Silke Thode, Dongxu Sun
  • Patent number: 6468754
    Abstract: Vectors of the invention facilitate selection of host cells having operably incorporated query genes, and substitution of the query gene with a different gene.
    Type: Grant
    Filed: April 17, 2001
    Date of Patent: October 22, 2002
    Assignee: Iconix Pharmaceuticals, Inc.
    Inventors: Amy L. Greene, Hua Zhou, Silke Thode, Kurt Jarnigan
  • Publication number: 20010044440
    Abstract: Compounds of formula I are effective modulators of p38 MAP kinase.
    Type: Application
    Filed: February 23, 2001
    Publication date: November 22, 2001
    Inventors: David J. Morgans, Silke Thode, Dongxu Sun